Mostrando 3 resultados de: 3
Filtros aplicados
Área temáticas
Anatomía humana, citología, histología(1)
Enfermedades(1)
Fisiología humana(1)
Medicina y salud(1)
Área de conocimiento
Farmacología(3)
Origen
scopus(3)
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and HLA-B Genotypes and Phenytoin Dosing: 2020 Update
ReviewAbstract: Phenytoin is an antiepileptic drug with a narrow therapeutic index and large interpatient pharmacokiPalabras claves:Autores:Adrián LLerena, Callaghan J.T., Caudle K.E., Fohner A.E., Formea C.M., Gaedigk A., Huddart R., Karnes J.H., Klein T.E., Mintzer S., Phillips E.J., Rettie A.E., Somogyi A.A., Ta Michael Lee M., Whirl-Carrillo M.Fuentes:scopusClinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 and CYP2C19 genotypes and dosing of selective serotonin reuptake inhibitors
ArticleAbstract: Selective serotonin reuptake inhibitors (SSRIs) are primary treatment options for major depressive aPalabras claves:Autores:Adrián LLerena, Bishop J.R., Caudle K.E., Chiulli D.L., Gaedigk A., Graham R.L., Hicks J.K., Ji Y., Klein T.E., Leckband S.G., Leeder J.S., Muller D.J., Sangkuhl K., Scott S.A., Skaar T.C., Stingl J.C.Fuentes:scopusCYP450 genotype and pharmacogenetic association studies: A critical appraisal
ReviewAbstract: Despite strong pharmacological support, association studies using genotype-pbkp_redicted phenotype aPalabras claves:drug metabolizing enzymes, ethnicity, Genotype, pharmacogenetic association studies, pharmacogenetics, phenoconversion, Phenotype, substrate-selectivity, Therapeutic drug monitoringAutores:Adrián LLerena, Eichelbaum M., Gaedigk A., Shah R.R., Smith R.L., Stingl J.C.Fuentes:scopus